Home › Hepatoblastoma › Ohio
Hepatoblastoma clinical trials in Ohio
3 studies for Hepatoblastoma are looking for participants at sites in Ohio.
Cities in Ohio
A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Sep 1, 2026 · NCT04928677Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingObservational study
All ages · All sexes · Updated Mar 18, 2026 · NCT05556642From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.